The Detroit carmaker is creating a domestic supply base to make EVs cheaper and profitable aided by Kurt Kelty, who landed Tesla’s top battery supplier in its early days.

General Motors announced record-breaking profits, which workers will see in their pockets with a $14,500 check.

US Dollar South African Rand, Gold Spot US Dollar, Dow Jones Industrial Average, Euro Stoxx 50. Read Adriaan Pask's latest article on Investing.com South Africa.

GM says it’s prepared for tariffs and discontinued EV incentives, but what about the nation’s EV charging network?

General Motors, the largest producer of cars in Mexico, won’t provide details on how it would react if President Trump imposes 25 percent tariffs from the two countries.

General Motors expects to save up to $1 billion annually by ending its Cruise robotaxi development program, CEO and Chair Mary Barra said Tuesday during

Piston Automotive LLC won a state grant Tuesday for a planned $55 million hydrogen fuel cell plant in Detroit supplying General Motors Co.

The tech-influenced Wall Street indices closed sharply lower on Monday, after DeepSeek unveiled advancements in AI technology that could disrupt the market, prompted fears of heightened competition and potential market share erosion to the US-based chipmakers.

US benchmark equity indexes were pointing higher before the open Tuesday as technology stocks make a recovery after closing the previous session lower amid the launch of a new open-source model from Chinese artificial intelligence startup DeepSeek.

Wall Street futures pointed higher pre-bell Tuesday, as tech issues recovered partially from Monday sell-offs that followed reports that China-based DeepSeek's AI model rivaled Western versions, but at lower development cost and use of computing power.

General Motors (NYSE: GM) slid 8.2% despite the company posting fourth-quarter results and a 2025 earnings forecast ahead of expectations. Boeing (NYSE: BA) shares, last up 6%, were volatile after the planemaker reported its biggest annual loss since 2020.

Johnson & Johnson (NYSE: JNJ) stock fell 1.5%, weighed by a hefty dip in sales of its blockbuster psoriasis treatment Stelara, even as the pharmaceutical firm posted better-than-expected fourth-quarter adjusted earnings and sales.